Citi analyst Filippo Falorni raised the firm’s price target on Colgate-Palmolive (CL) to $105 from $95 and keeps a Buy rating on the shares. the company reported a “solid” Q4 earnings beat with accelerating trends, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL:
- Colgate-Palmolive price target raised to $100 from $87 at Morgan Stanley
- Colgate-Palmolive: Strengthening Earnings Visibility and Long-Term Growth Through Premiumization and the 2030 Strategic Plan
- Colgate-Palmolive price target raised to $94 from $86 at Wells Fargo
- Colgate-Palmolive: Premium-Valued Emerging Markets and Pet Nutrition Strength Support Buy Rating and Upside into 2026
- Colgate-Palmolive price target raised to $94 from $91 at Goldman Sachs